Online analysis based on ESC 2022 mentions
in the period 22 August – 02 September 2022

26 Aug – 29 Aug 2022

The European Society of Cardiology welcomed delegates from across the globe to celebrate 70 years since the first ESC Congress. The world’s largest conference in cardiovascular medicine hosted a four-day agenda on the latest developments within the domain. This year’s agenda solely focused on important content for clinical practice and research, with a spotlight on ‘Cardiac Imaging’ and its profound implications for prevention, clinical decision-making, diagnosis and follow-up therapeutic procedures.

Activity Over Time:

Brand Buzz:

TRAINING & EDUCATION

HEART FAILURE

DIAGNOSTICS

PHARMACEUTICALS

PREVENTATIVE CARDIOLOGY

Posts about the leading 5 topics are 56% of all categorised posts and 21% of all posts, related to the event.

Training & Education, as well as Heart Failure still lead the scoreboard. In comparison to ESC’s 2021 Brand Buzz report, there are two entirely new topics–Diagnostics and Pharmaceuticals, whereas COVID-19 and Big Data Applications in Healthcare have fallen off the ranks, respectively to 9th and 14th place.

In LinkedIn only, Heart Failure, Diagnostics and Pharmaceuticals scored higher than Training & Education.

Relative shares are calculated out of all categorised posts within the respective social media.

Competitive Brand Buzz:

Influencers & Online Buzz Strategies:

What did the highest-ranking companies in Brand Buzz analysis talk about? Click on the three dots below to flip between tabs.

INFLUENCER & INDUSTRY

CAMPAIGN & PITCH

Delegates were able to discover a range of new data from a new exploratory analysis of FIDELITY with a prime focus on mortality in patients with kidney disease (CKD) and type 2 diabetes (T2D) under the Kerendia treatment or placebo. Bayer's presentation covered a total of three late-breaking abstracts, highlighting the company's commitment to improving the lives of patients with kidney and cardiovascular diseases.

INFLUENCER & INDUSTRY

CAMPAIGN & PITCH

AstraZeneca unfolds the cover of a long-term heart failure research. The research studied opportunities for exploring novel target therapies that could potentially slow down, halt and reverse heart failure progression.

INFLUENCER & INDUSTRY

CAMPAIGN & PITCH

Sanofi focused on the ever so popular topic of influenza prevention through vaccines. They spoke about the next generation influenza vaccines with a sole focus of protecting as many people as possible against flu and the complications that could potentially come with it.